2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow SH229: new trials by email Literature Review of SH229 trials Research Report on SH229
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Drug-drug Interaction Study of SH229 Tablets and Daclatasvir Dihydrochloride Tablets in Healthy Subjects SH229, Daclatasvir dihydrochloride - Drug Interactions | Phase 1 | Completed | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 28 | 2018-11-19 | 2019-08-13 |
| Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection SH229, Placebos - HCV Infection | Phase 1 | Completed | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 30 | 2018-07-07 | 2018-08-28 |
Hepatitis C (1)
Nanjing Sanhome Pharmaceutical, Co., Ltd. (2)
China (2)
Yanhua Ding, MD (2)